Why are Medical Developments shares crashing 11% lower today?

The Medical Developments International Ltd (ASX: MVP) share price is crashing lower on a day of sharp falls across most ASX sectors.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medical Developments International Ltd (ASX: MVP) share price is crashing lower on a day which has seen a sharp fall across most of the ASX's major sectors. 

At the time of writing, the S&P/ASX 200 Index (INDEXASX: XJO) is down 2.14% while Medical Developments shares are trading 10.9% lower at $9.58.

So, what appears to be behind this fall?

What does Medical Developments do?

Medical Developments is an Australia-based healthcare company that offers a range of open and closed circuit anaesthetic machines to the veterinary market.

In addition to veterinary equipment, the company also has a range of products in the areas of pain management, asthma and resuscitation.

What's behind today's sharp fall?

There doesn't appear to be any major company announcement or activity that has triggered today's fall.

In my view, today's fall is most likely a market correction after Medical Developments' very strong run on the ASX since September last year. This correction appears to have begun last Friday when the Medical Developments share price fell by 4.5%.

During the period from 10 September 2019 to the close of trade last Thursday, Medical Developments shares had gone up by a massive 156%.

I don't think the company's fundamentals are strong enough to continue to support such a continued high growth rate. Therefore, a market correction, triggered by the ASX's wider falls today, is not surprising.

Looking back further over the past two years, the Medical Developments share price had fallen back from the period of January 2018 until January 2019, further supporting the case for a market correction.

Strong recent financials

Medical Developments released its 1H20 results to the market last Wednesday, reporting an 82% increase in net profit after tax to $240,000. This was up from the $132,000 that it recorded in 1H19.

Meanwhile, gross revenue for the period came in at $11.2 million, up 15% from $9.8 million in the prior corresponding period. Gross margins remained strong and largely consistent with the prior year at 67%, while earnings before interest, tax, depreciation and amortisation (EBITDA) was up 21% to $1.5 million.

Foolish takeway

Today's share price falls appears to be a market correction to a strong recent run for Medical Developments on the ASX since last September.

I believe the underlying fundamentals of Medical Developments remain strong, and that the company is positioned for strong growth over the next year or two.

Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Medical Developments International Limited. The Motley Fool Australia has recommended Medical Developments International Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors finished the trading week on a sour note today.

Read more »

Happy teen friends jumping in front of a wall.
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors are sending these four ASX 200 stocks soaring this week. But why?

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Broker Notes

Bell Potter says this growing ASX 200 stock can rise over 40%

Big returns could be on the cards for buyers of this stock.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A couple makes silly chip moustache faces and take a selfie on their phone.
Share Market News

Which delivered superior returns in FY25: CSL, A2 Milk, or Telstra shares?

We review the share price growth and dividend income delivered to investors in FY25.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why IGO, Johns Lyng, Lynas, and Web Travel shares are pushing higher today

These shares are ending the week on a high. But why?

Read more »

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

Why Imricor, Ora Banda, Ventia, and Vulcan shares are dropping today

These shares are ending the week in the red. But why?

Read more »

Man with rocket wings which have flames coming out of them.
Resources Shares

Up 23% today, why Macquarie forecasts this ASX 200 mining stock could rocket another 33%

Macquarie forecasts more outsized gains to come for this surging ASX 200 mining stock.

Read more »